Mode
Text Size
Log in / Sign up
N/A Completed N=11 Randomized Treatment

Cerebrovascular Dysregulation in Chronic Kidney Disease

Chronic Kidney Diseases
Source: ClinicalTrials.gov NCT05571605 ↗
Enrolled (actual)
11
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcomePrimary: Mean Arterial Pressure-Middle Cerebral Artery Blood Velocity Very Low Frequency Phase (Radians) — 1.38; 1.12; 1.40; 1.60 Radians — p=0.05

Summary

The purpose of this study is to test whether or not regular exercise training may improve brain blood flow regulation in patients with chronic kidney disease (CKD).

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Arterial Pressure-Middle Cerebral Artery Blood Velocity Very Low Frequency Phase (Radians)
1.38; 1.12; 1.40; 1.60 0.05
PRIMARY
Mean Arterial Pressure-Middle Cerebral Artery Blood Velocity Very Low Frequency Gain (cm/s/mmHg)
0.65; 0.67; 0.77; 0.63

Eligibility Criteria

Inclusion Criteria

  • Individuals with chronic kidney disease stages III-IV.

Exclusion Criteria

  • Heart failure
  • Chronic obstructive pulmonary disease
  • Uncontrolled hypertension or hypotension
  • Pregnancy or plans to become pregnant
  • Inability to exercise on a stationary bicycle
  • Current participation in exercise more than 20 minutes twice per week
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05571605). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search